JPH01139564A - N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound - Google Patents
N-substituted indole ester compound, production thereof, testing composition and testing tool using said compoundInfo
- Publication number
- JPH01139564A JPH01139564A JP63215379A JP21537988A JPH01139564A JP H01139564 A JPH01139564 A JP H01139564A JP 63215379 A JP63215379 A JP 63215379A JP 21537988 A JP21537988 A JP 21537988A JP H01139564 A JPH01139564 A JP H01139564A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- toluenesulfonyl
- halogen atom
- tables
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 N-substituted indole ester compound Chemical class 0.000 title claims abstract description 59
- 150000001875 compounds Chemical class 0.000 title claims abstract description 17
- 239000000203 mixture Substances 0.000 title claims description 25
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 108090000371 Esterases Proteins 0.000 claims abstract description 21
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 21
- 108091005804 Peptidases Proteins 0.000 claims abstract description 18
- 239000004365 Protease Substances 0.000 claims abstract description 18
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 16
- 125000005843 halogen group Chemical group 0.000 claims abstract description 16
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 10
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract description 7
- 125000004442 acylamino group Chemical group 0.000 claims abstract description 6
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 6
- 125000006239 protecting group Chemical group 0.000 claims abstract description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 239000012954 diazonium Substances 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000003368 amide group Chemical group 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 5
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 5
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 2
- 150000003973 alkyl amines Chemical class 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 abstract description 7
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical group O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 239000011541 reaction mixture Substances 0.000 description 15
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000000123 paper Substances 0.000 description 11
- 238000010898 silica gel chromatography Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- PCKPVGOLPKLUHR-UHFFFAOYSA-N indoxyl Chemical class C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000001632 sodium acetate Substances 0.000 description 5
- 235000017281 sodium acetate Nutrition 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229960003767 alanine Drugs 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 238000009423 ventilation Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- DXFLXXYSOGECDN-UHFFFAOYSA-N 1h-indol-2-yl acetate Chemical compound C1=CC=C2NC(OC(=O)C)=CC2=C1 DXFLXXYSOGECDN-UHFFFAOYSA-N 0.000 description 2
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005968 1-Decanol Substances 0.000 description 1
- SANDMWGTFWJWOL-UHFFFAOYSA-N 2-(methoxyamino)-2-phenylacetic acid Chemical compound CONC(C(O)=O)C1=CC=CC=C1 SANDMWGTFWJWOL-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はN−置換インドールエステル化合物、その製造
法ならびに該化合物を用いたエステラーゼ又はプロテア
ーゼ測定用試験組成物およびそれを担持した試験具に関
する。本発明によって提供されるN−置換インドールエ
ステル化合物はエステラーゼ又はプロテアーゼ例えば白
血球の検出に有効に利用される。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to an N-substituted indole ester compound, a method for producing the same, a test composition for measuring esterase or protease using the compound, and a test device carrying the same. The N-substituted indole ester compounds provided by the present invention are effectively utilized for detecting esterases or proteases such as leukocytes.
尿または透析液等の中に白血球またはエステラーゼが含
まれている場合には腎臓及び泌尿生殖器路の疾病または
透析部位において炎症等が進行しているものと推定しう
る。従ってこれらの疾病を速やかに診断、治療するため
には上記尿、透析液等中の白血球またはエステラーゼを
正確に検出することが重要である。本発明のN−置換イ
ンドールエステル化合物はこのようなエステラーゼの検
査用試薬として好適に使用される。If leukocytes or esterase are contained in the urine or dialysate, it can be assumed that a disease in the kidneys and genitourinary tract or inflammation is progressing at the dialysis site. Therefore, in order to promptly diagnose and treat these diseases, it is important to accurately detect leukocytes or esterase in the urine, dialysate, etc. The N-substituted indole ester compound of the present invention is suitably used as a test reagent for such esterases.
エステラーゼ又はプロテアーゼ検出用試験具は、エステ
ル化合物、ジアゾニウム塩化合物、緩衝剤及び活性剤を
含浸する担体からなり、試料中にエステラーゼ又はプロ
テアーゼが存在するとエステル化合物が加水分解されて
反応性の高い水素基を有する化合物を生じ、これとジア
ゾニウム塩化合物がカップリングすることにより発色す
る。エステル化合物として3−(N−トルエンスルホニ
ル−し−アラニロキシ)−インドール(特公昭59−3
475号)と3−(N−)ルエンスルホニルーし一アラ
ニロキシ)−5−フェニルピロール(特開昭60−26
0558号)が知られ実用化されている。The test device for detecting esterase or protease consists of a carrier impregnated with an ester compound, a diazonium salt compound, a buffer, and an activator.If esterase or protease is present in the sample, the ester compound is hydrolyzed and generates highly reactive hydrogen groups. A compound having the above is produced, and color is developed by coupling this with the diazonium salt compound. As an ester compound, 3-(N-toluenesulfonyl-shi-alanyloxy)-indole (Japanese Patent Publication No. 1983-3
No. 475) and 3-(N-)luenesulfonyl-monoaranyloxy)-5-phenylpyrrole (JP-A-60-26
No. 0558) is known and put into practical use.
しかし、これらのエステル化合物は実用化されてはいる
が判定時間が120秒と他の尿中成分検出試験片と比べ
て著しく時間を要するという欠点があった。However, although these ester compounds have been put into practical use, they have the disadvantage that the determination time is 120 seconds, which is significantly longer than other urine component detection test strips.
従って本発明は新規なN−置換インドールエステル化合
物、その製造法ならびに該化合物を用いたエステラーゼ
又はプロテアーゼ測定用試験組成物及びそれを担持した
試験具を提供することを目的とする。Therefore, an object of the present invention is to provide a novel N-substituted indole ester compound, a method for producing the same, a test composition for measuring esterase or protease using the compound, and a test device supporting the same.
本発明は、−服代
%式%()
〔式中R1はアルコキシ基、アルアルコキシ基またはア
リールオキシ基を示すが、ハロゲン原子。The present invention is based on the following formula: -% formula () [In the formula, R1 represents an alkoxy group, an aralkoxy group, or an aryloxy group, and is a halogen atom.
アルコキシ基またはニトロ基で置換されていてもよい。It may be substituted with an alkoxy group or a nitro group.
または、式中R1はアルキルスルホニル基またはアリー
ルスルホニル基を示す。R2は水素原子、ハロゲン原子
、ヒドロキシ基、カルボキシル基、アシルアミノ基、ニ
トロ基、カルボキシル基、アルコキシカルボニル基、ア
ルコキシ基またはアミド基を表す。X、Yはアミノ基の
常用保護基を表す。〕
で表されるN−置換インドールエステル化合物である。Alternatively, R1 in the formula represents an alkylsulfonyl group or an arylsulfonyl group. R2 represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxyl group, an acylamino group, a nitro group, a carboxyl group, an alkoxycarbonyl group, an alkoxy group, or an amide group. X and Y represent commonly used protecting groups for amino groups. ] It is an N-substituted indole ester compound represented by these.
また、本発明は一般式(2)
〔式中R1はアルコキシ基、アルアルコキ基またはアリ
ールオキシ基を示すが、ハロゲ原子、アルコキシ基また
はニトロ基で置換さていてもよい。The present invention also provides a compound of the general formula (2) [wherein R1 represents an alkoxy group, an aralkoxy group, or an aryloxy group, but may be substituted with a halogen atom, an alkoxy group, or a nitro group.
または、式中R’ はアルキルスルホニル基またはアリ
ールスルホニル基を示す。Rtは水素原子。Alternatively, R' in the formula represents an alkylsulfonyl group or an arylsulfonyl group. Rt is a hydrogen atom.
ハロゲン原子、ヒドロキシ基、カルボキシル基。Halogen atoms, hydroxyl groups, carboxyl groups.
アシルアミノ基、ニトロ基、カルボキシル基、アアコキ
シカルボニル基、アルコキシ基またはアミド基を表す。Represents an acylamino group, nitro group, carboxyl group, aacoxycarbonyl group, alkoxy group or amide group.
〕
で表される化合物と
一般式(7)
〔式中Zはヒドロキシ基、ハロゲン原子、アルコキシカ
ルボニルオキシ基またはイミダゾール基等を示す。X、
Yはアミノ基の常用保護基を表す。〕で表される化合物
とを縮合させることを特徴とする一服代山
Rl (I)〔式中R1は
アルコキシ基、アルアルコキシ基またはアリールオキシ
基を示すが、ハロゲン原子。] The compound represented by the general formula (7) [In the formula, Z represents a hydroxy group, a halogen atom, an alkoxycarbonyloxy group, an imidazole group, etc. X,
Y represents a commonly used protecting group for amino groups. Ippukudaiyama Rl (I) [wherein R1 represents an alkoxy group, an aralkoxy group or an aryloxy group, and is a halogen atom].
アルコキシ基またはニトロ基で置換されていてもよい、
または、式中R’はアルキルスルホニル基またはアリー
ルスルホニル基を示す。R2は水素原子、ハロゲン原子
、ヒドロキシ基、カルボキシル基、アシルアミノ基、ニ
トロ基、カルボキシル基、アルコキシカルボニル基、ア
ルコキシ基またはアミド基を表す。X、Yはアミノ基の
常用保護基を表わす。〕
で表されるN−i換インドールエステル化合物の製造法
を提供するものである。Optionally substituted with an alkoxy group or a nitro group,
Alternatively, R' in the formula represents an alkylsulfonyl group or an arylsulfonyl group. R2 represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxyl group, an acylamino group, a nitro group, a carboxyl group, an alkoxycarbonyl group, an alkoxy group, or an amide group. X and Y represent commonly used protecting groups for amino groups. ] Provides a method for producing an N-i substituted indole ester compound represented by the following.
さらに、本発明によれば上記N−W換イフィンドールエ
ステル化合物び一般式
〔式中R3はアルキル基、アルコキシ基、ハロゲン原子
又は水素原子を示し、R4はアルキレン基を示し、m、
nは同−又は異なった1、2.3の整数を示し、Zは安
定化性アニオンを示す。又Aは
R:I
アルキルアミン又は酸素原子を示す。〕で表されるジア
ゾニウム塩化合物を含有するエステラーゼまたはプロテ
アーゼ測定用試験組成物が提供される。Furthermore, according to the present invention, the N-W substituted ifhindole ester compound and the general formula [wherein R3 represents an alkyl group, an alkoxy group, a halogen atom or a hydrogen atom, and R4 represents an alkylene group, m,
n represents the same or different integers of 1 or 2.3, and Z represents a stabilizing anion. Further, A represents R:I alkylamine or an oxygen atom. ] A test composition for measuring esterase or protease containing a diazonium salt compound represented by the following is provided.
さらに本発明によれば、前記組成物を担体に担持させて
なるエステラーゼ又はプロテアーゼ測定用試験具が提供
される。Furthermore, according to the present invention, there is provided a test device for measuring esterase or protease, which comprises the composition supported on a carrier.
本発明の式(Ilで示されるN−置換インドールエステ
ル化合物は以下の図に示す経路で製造される。The N-substituted indole ester compound of formula (Il) of the present invention is produced by the route shown in the diagram below.
C)121□
R’
すなわち、N−1換ジカルボン酸(6)を酢酸ナトリウ
ム存在下、無水酢酸と加熱することにより閉環せしめN
−9換−3−アセトキシインドール■を得、該化合物の
アルカリ加水分解によってN−置換インドキシル(I[
)が得られる。N−置換インドキシル(罰を前記式(2
)で示されるカルボン酸誘導体と縮合することにより、
N−置換インドール化合物(1)が得られる。好ましく
はカルボン酸化合物(2)とN−置換インドキシル(5
)を、塩化メチレン中でN、 N’−ジシクロへキシル
カルボジイミド等の脱水剤と4−ジメチルアミノピリジ
ン等の反応助剤と共に反応する事によって製造される。C) 121□ R' That is, N-1 substituted dicarboxylic acid (6) is ring-closed by heating with acetic anhydride in the presence of sodium acetate.
-9-substituted-3-acetoxyindole ■ was obtained, and N-substituted indoxyl (I[
) is obtained. N-substituted indoxyl (penalized by the above formula (2
) By condensing with the carboxylic acid derivative shown in
An N-substituted indole compound (1) is obtained. Preferably carboxylic acid compound (2) and N-substituted indoxyl (5
) in methylene chloride with a dehydrating agent such as N,N'-dicyclohexylcarbodiimide and a reaction aid such as 4-dimethylaminopyridine.
本発明のN−置換インドールエステル化合物[11は前
述したようにエステラーゼ又はプロテアーゼの測定にお
ける基質として使用され、特に尿、透析液中の白血球の
検出に有利に使用される。As mentioned above, the N-substituted indole ester compound [11] of the present invention is used as a substrate in the measurement of esterase or protease, and is particularly advantageously used in the detection of leukocytes in urine and dialysate.
かかるエステラーゼ又はプロテアーゼ測定用試験具は本
発明のN−置換インドールエステル化合物(I)、ジア
ゾニウム塩化合物ならびに必要により緩衝剤、活性剤、
安定剤、湿潤剤および溶剤からなる組成物を含浸する担
体からなる。Such a test device for measuring esterase or protease contains the N-substituted indole ester compound (I) of the present invention, a diazonium salt compound, and if necessary, a buffer, an activator,
It consists of a carrier impregnated with a composition consisting of stabilizers, wetting agents and solvents.
ジアゾニウム塩化合物の代表的な化合物としてハ、N、
N′−ヒス(3−トメキシフェニル)ピペラジン−4
’、4’−ジジアゾニウムビステトラフルオロポレート
または0,0′−ビス(3−クロロフェニル)エチレン
グリコール−4Z 4+−ジジアゾニウムビステトラフ
ルオロボレートが挙げられる。Typical diazonium salt compounds include C, N,
N'-his(3-tomexyphenyl)piperazine-4
',4'-didiazonium bistetrafluoroporate or 0,0'-bis(3-chlorophenyl)ethylene glycol-4Z 4+-didiazonium bistetrafluoroborate.
ジアゾニウム塩化合物はたとえば下記式〔式中R5はア
ルキル基、アルコキシ基、ハロゲン原子又は水素原子を
示し、m、nは同−又は異なった1、2.3の整数を示
す。〕で表されるアミノ化合物をし冷鉱酸水溶液に溶か
すか懸濁させて、亜硝酸ナトリウムで処理することによ
って製造される。好ましくは上記アミノ化合物を冷却し
た6N塩化水素水溶液等は適当な鉱酸に溶かすか懸濁さ
せ、この溶液に亜硝酸ナトリウム水溶液を加え反応させ
る。さらに生成したジアゾニウム塩溶液O℃にて35%
テトラフルオロホウ酸と数時間反応させる。反応終了後
所望の生成物は常法に従って反応混合物中から採取され
る。The diazonium salt compound is, for example, represented by the following formula [wherein R5 represents an alkyl group, an alkoxy group, a halogen atom or a hydrogen atom, and m and n represent the same or different integers of 1 or 2.3. It is produced by dissolving or suspending the amino compound represented by ] in a cold mineral acid aqueous solution and treating it with sodium nitrite. Preferably, a 6N aqueous hydrogen chloride solution containing the above amino compound is dissolved or suspended in a suitable mineral acid, and an aqueous sodium nitrite solution is added to this solution for reaction. Further generated diazonium salt solution 35% at O℃
React with tetrafluoroboric acid for several hours. After the reaction is complete, the desired product is collected from the reaction mixture in a conventional manner.
例えば、生成した沈澱物を濾過により集め、乾燥するこ
とにより所望の生成物を得ることができる。For example, the desired product can be obtained by collecting the generated precipitate by filtration and drying it.
緩衝剤は試験具上のpi値を一定に保つために使用され
、例えばトリス−(ヒドロキシメチル)−アミノメタン
緩衝剤、燐酸塩緩衝剤、ホウ酸塩緩衝剤、バルビッール
酸塩緩衝剤又はアミノ酸緩衝剤が挙げられ試験具を試料
中に浸漬した際のpif値が6〜10の範囲に維持でき
るものが好ましい。この組成物は直接尿等の被検液中に
滴下して使用するか、あるいはこの組成物中に尿等の被
検液を滴下して使用することができる。Buffers are used to keep the pi value constant on the test device, such as tris-(hydroxymethyl)-aminomethane buffers, phosphate buffers, borate buffers, barbiturate buffers or amino acid buffers. It is preferable that the pif value can be maintained in the range of 6 to 10 when the test device is immersed in the sample. This composition can be used by dropping it directly into a test liquid such as urine, or by dropping a test liquid such as urine into this composition.
さらに本発明のエステラーゼ又はプロテアーゼ測定用試
験具は、上記組成物を担体に担持させたものである。担
体としては濾紙、ガラス繊維、プラスチック素材からな
る不織布が好適であり、溶剤に溶けたり反応したすせず
、かつ上記組成物を吸収するものであればよい。Furthermore, the test device for measuring esterase or protease of the present invention has the above composition supported on a carrier. Suitable carriers include filter paper, glass fibers, and nonwoven fabrics made of plastic materials, as long as they do not dissolve or react with solvents and absorb the above composition.
上記試験組成物および試験具に用いられるN−置換イン
ドールエステル化合物(1)およびその他の試薬の量は
特に重要ではなく、適宜決定される。The amounts of the N-substituted indole ester compound (1) and other reagents used in the test composition and test device are not particularly important and are determined as appropriate.
即ち、検出対象のエステラーゼ又はプロテアーゼに対し
て反応させ、呈色反応を起こさせるに十分な量が選択さ
れる。That is, an amount sufficient to react with the esterase or protease to be detected and cause a color reaction is selected.
次に実施例、および試験例を示して本発明をさらに具体
的に説明する。Next, the present invention will be explained in more detail with reference to Examples and Test Examples.
実施例1
1−メトキシ−3−(N−(p−)ルエンスルホニル)
−L−アラニルオキシューインドールN−ヒドロキシフ
ェニルグリシン−2−カルボン酸2.0g (9,47
+*5ol)をD M F 10d1.32g(33,
0gmol)の60%水素化ナトリウム、5.38g(
37,9mmol)のヨウ化メチルを加え、N2気流中
、室温で2時間撹拌反応した。反応混合物に10%水酸
化ナトリウム3Id加え、0°Cでさらに30分間撹拌
後、1%塩酸を加えて酸性とした後、エーテル200戚
で抽出した。エーテル層は無水硫酸マグネシウムで乾燥
した後、減圧濃縮し、残渣をシリカゲルカラムクロマト
グラフィーで精製し、N−メトキシフェニルグリシン−
2−カルボン酸1.24gを得た。Example 1 1-Methoxy-3-(N-(p-)luenesulfonyl)
-L-alanyloxyindole N-hydroxyphenylglycine-2-carboxylic acid 2.0 g (9,47
+*5ol) to D M F 10d1.32g (33,
0 gmol) of 60% sodium hydride, 5.38 g (
37.9 mmol) of methyl iodide was added, and the mixture was stirred and reacted at room temperature for 2 hours in a N2 stream. 10% sodium hydroxide (3Id) was added to the reaction mixture, and the mixture was further stirred at 0°C for 30 minutes, made acidic by adding 1% hydrochloric acid, and extracted with ether 200. The ether layer was dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography to obtain N-methoxyphenylglycine.
1.24 g of 2-carboxylic acid was obtained.
2−5dの無水酢酸に3.0g(13,32mmol)
上記化合物と2.0gの酢酸ナトリウムを加え4時間加
熱還流した。反応混合物を氷水中に投入し、析出する粗
結晶をろ集し、水洗後減圧乾燥した。粗生成物をシリカ
ゲルカラムクロマトグラフィーで精製し1.62 gの
1−メトキシ−2−アセトキシインドールを得た。3.0 g (13.32 mmol) in 2-5d acetic anhydride
The above compound and 2.0 g of sodium acetate were added and heated under reflux for 4 hours. The reaction mixture was poured into ice water, and the precipitated crude crystals were collected by filtration, washed with water, and then dried under reduced pressure. The crude product was purified by silica gel column chromatography to obtain 1.62 g of 1-methoxy-2-acetoxyindole.
20dのメタノールに溶解した3、0g(14,6ms
+ol)の上記アセトキシインドールを3日フラスコに
取り導入管上、反応溶液中にN2を通気する。通気を継
続したまま、−8“Cまで反応溶液を冷却し、滴下ロー
トより脱酸素化10%水酸化カリウム水溶液18戚を加
え、−8°Cで1時間撹拌反応させた後、脱酸素化クエ
ン酸水溶液(2N)30dを加え、さらに0°Cで30
分間撹拌を継続する。反応混合物を脱酸素化クロロホル
ムで抽出しクロロホルム層を無水硫酸マグネシウムで乾
燥後減圧乾固し、粗1−メトキシインドキシル2.18
gを得た。3.0 g dissolved in 20 d methanol (14.6 ms
+ol) of the above acetoxyindole was placed in a flask for 3 days, and N2 was bubbled into the reaction solution over the inlet tube. While continuing ventilation, the reaction solution was cooled to -8"C, and a deoxygenated 10% potassium hydroxide aqueous solution 18 was added from the dropping funnel, and the reaction was stirred at -8°C for 1 hour, followed by deoxygenation. Add 30 d of citric acid aqueous solution (2N) and further cool for 30 d at 0°C.
Continue stirring for minutes. The reaction mixture was extracted with deoxygenated chloroform, and the chloroform layer was dried over anhydrous magnesium sulfate and evaporated to dryness to give 2.18 g of crude 1-methoxyindoxyl.
I got g.
2.0g(12,26mmol)の粗1−メトキシイン
ドキシルと、6.0g(24,7mmol)のN−p−
トル:r−7スJLtホニルーL−アラニンを脱酸素化
塩化メチレン15dに溶解し、冷却下977■(8,0
mmol)のジメチルアミノピリジンと4.95g(2
4,0mmol)のジシクロへキシルカルボジイミドを
加え、N2気流中、室温で10時間撹拌反応した。反応
混合物を減圧濃縮後シリカゲルカラムクロマトグラフィ
ーで精製し、1−メトキシ−3−((N−p−トルエン
スルホニル)−L−アラニルオキシューインドール4.
33g(11,1mmol)を得た。2.0 g (12.26 mmol) of crude 1-methoxyindoxyl and 6.0 g (24.7 mmol) of N-p-
Tor: r-7s JLt Honyl-L-alanine was dissolved in 15 d of deoxygenated methylene chloride, and 977 μm (8,0
mmol) of dimethylaminopyridine and 4.95 g (2
4.0 mmol) of dicyclohexylcarbodiimide was added thereto, and the mixture was stirred and reacted at room temperature for 10 hours in a N2 stream. The reaction mixture was concentrated under reduced pressure and purified by silica gel column chromatography to obtain 1-methoxy-3-((N-p-toluenesulfonyl)-L-alanyloxy-indole4.
33 g (11.1 mmol) was obtained.
NMR(δppm、CDCj23)
6.62−7.85(m、98) 、5.70(m、
18) 、4.22(m、 LH) 。NMR (δppm, CDCj23) 6.62-7.85 (m, 98), 5.70 (m,
18), 4.22 (m, LH).
3.64(s、3)1)、2.46(s、3H)、1.
66(d、J=6tlz、38)IR(シcm−’、
CH(/!:+) 1760実施例2
1−ベンジルオキシ−3−(N−(p−)ルエンスルホ
ニル)−1−アラニルオキシ)−5−ブロモインドール
(Tsは実施例1と同じ)
3.0g(7,89mnol)の4−ブロモN−ヒドロ
キシフェニルグリシン−2−カルボン酸を1戚のDMF
に溶解し、1.26g(31,6mmol)の60%水
素化ナトリウム3.50g (27,6mmol)のベ
ンジルクロライドを加え室温で5時間撹拌反応した。反
応混合物をOoCに冷却し、3%水酸化ナトリウム3d
を加えさらに30分撹拌後、1%塩酸で酸性とした後、
エーテル200 d抽出した。エーテル層は無水硫酸マ
グネシウムで乾燥し、減圧濃縮し、残渣をシリカゲルカ
ラムクロマトグラフィーで精製し、4−ブロモN−ベン
ジルオキシフェニルグリシン−2−カルボン酸2.7g
を得た。3.64 (s, 3) 1), 2.46 (s, 3H), 1.
66(d, J=6tlz, 38)IR(shicm-',
CH(/!:+) 1760 Example 2 1-benzyloxy-3-(N-(p-)luenesulfonyl)-1-alanyloxy)-5-bromoindole (Ts is the same as Example 1) 3.0 g (7,89 mnol) of 4-bromo N-hydroxyphenylglycine-2-carboxylic acid was dissolved in 1 relative DMF.
1.26 g (31.6 mmol) of 60% sodium hydride and 3.50 g (27.6 mmol) of benzyl chloride were added thereto, and the reaction was stirred at room temperature for 5 hours. Cool the reaction mixture to OoC and add 3% sodium hydroxide 3d
After adding and stirring for another 30 minutes, acidified with 1% hydrochloric acid,
Extracted with ether 200 d. The ether layer was dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography to obtain 2.7 g of 4-bromo N-benzyloxyphenylglycine-2-carboxylic acid.
I got it.
20dの無水酢酸に3.0g(7,89nuwol)の
上記化合物と1.5gの酢酸ナトリウムを加え、5時間
加熱還流した。反応混合物を氷水中に投入し、析出する
粗結晶をろ集し、水冷後減圧乾燥した。残渣をシリカゲ
ルカラムクロマトグラフィーで精製し、1−ベンジルオ
キシ−3−アセトキシ−5−ブロモインドール1.26
gを得た。3.0 g (7.89 nuwol) of the above compound and 1.5 g of sodium acetate were added to 20 d of acetic anhydride, and the mixture was heated under reflux for 5 hours. The reaction mixture was poured into ice water, and the precipitated crude crystals were collected by filtration, cooled with water, and then dried under reduced pressure. The residue was purified by silica gel column chromatography to give 1.26% of 1-benzyloxy-3-acetoxy-5-bromoindole.
I got g.
20/dのメタノールに溶解した3、0g(8,32m
mol)の上記アセトキシインドールを30フラスコに
取り導入管上、反応溶液中にN2を通気する。通気を継
続したまま、−8°Cまで反応溶液を冷却し、滴下ロー
トより脱酸素化10%水酸化カリウム水溶液14dを加
え一8℃で1時間撹拌反応させた後、脱酸素化クエン酸
水溶液(2N)25dを加え、さらにOoCで30分間
撹拌を継続する。反応混合物を脱酸素化クロロホルムで
抽出しクロロホルム層を無水硫酸マグネシウムで乾燥後
減圧乾固し、粗1−ベンジルオキシー5−ブロモインド
キシル2.15gを得た。3.0 g (8.32 m
mol) of the above acetoxyindole was placed in a 30 flask, and N2 was bubbled into the reaction solution over the inlet tube. While continuing ventilation, the reaction solution was cooled to -8°C, 14 d of deoxygenated 10% potassium hydroxide aqueous solution was added from the dropping funnel, and the reaction was stirred at -8°C for 1 hour, followed by deoxygenated citric acid aqueous solution. Add 25 d of (2N) and continue stirring for an additional 30 minutes at OoC. The reaction mixture was extracted with deoxygenated chloroform, and the chloroform layer was dried over anhydrous magnesium sulfate and then dried under reduced pressure to obtain 2.15 g of crude 1-benzyloxy-5-bromo indoxyl.
2.0g(6,29mmol)の上記キンドキシルと、
3.05g(12,6mmol)のN−p−)ルエンス
ルホニルーL−アラニンを脱酸素化塩化メチレン12戚
に溶解し冷却下61L [ng(5,0mmol)のジ
メチルアミノピリジンと2.60g(12,6mmol
)のジシクロへキシルカルボジイミドを加え、N2気流
中室温で10時間撹拌反応した。反応混合物を減圧濃縮
後、シリカゲルカラムクロマトグラフィーで精製し、1
−ベンジルオキシ−3−(N−(p−)ルエンスルホニ
ル)−L−アラニルオキシ〕−5−ブロモインドール3
.22g (5,93mmol)を得る。2.0 g (6.29 mmol) of the above kindoxil,
3.05 g (12.6 mmol) of N-p-)luenesulfonyl-L-alanine was dissolved in deoxygenated methylene chloride 12 and cooled to 61 L [ng (5.0 mmol) of dimethylaminopyridine and 2.60 g ( 12.6 mmol
) dicyclohexylcarbodiimide was added, and the mixture was stirred and reacted at room temperature in a N2 stream for 10 hours. After concentrating the reaction mixture under reduced pressure, it was purified by silica gel column chromatography.
-benzyloxy-3-(N-(p-)luenesulfonyl)-L-alanyloxy]-5-bromoindole 3
.. 22 g (5.93 mmol) are obtained.
NMR(δppm、 CDCj2 s)6.72−7.
96(n+、13B)、5.68(m、1M)、5.1
8(s、2H)。NMR (δppm, CDCj2s) 6.72-7.
96 (n+, 13B), 5.68 (m, 1M), 5.1
8 (s, 2H).
4.22(m、IH)、2.44(s、38)、1.5
8(d、J=6Hz、3H)IR(シcm−’、CHC
j23) 1760実施例3
l−(p−)ルエンスルホニル)−3−(N−(p−ト
ルエンスルホニル)−L−アラニルオキシ〕−インドー
ル
I
T、 (T、は実施例1に同じ)20dの無
水酢酸に3.0g(8,59開o1)のN−(p−トル
エンスルホニル)−フェニルグリシン−2−カルボン酸
と1.5gの酢酸ナトリウムを加え、5時間加熱還流し
た。反応混合物を氷水中に投入し、析出する粗結晶をろ
集し水洗減圧乾燥した。これをシリカゲルカラムクロマ
トグラフィーで精製し、1.37 gの1−(p−)ル
エンスルホニル)−3−アセトキシインドールを得た。4.22 (m, IH), 2.44 (s, 38), 1.5
8(d, J=6Hz, 3H) IR(cm-', CHC
j23) 1760 Example 3 l-(p-)toluenesulfonyl)-3-(N-(p-toluenesulfonyl)-L-alanyloxy]-indole I T, (T is the same as Example 1) 20d anhydride 3.0 g (8,59 ml) of N-(p-toluenesulfonyl)-phenylglycine-2-carboxylic acid and 1.5 g of sodium acetate were added to acetic acid and heated under reflux for 5 hours.The reaction mixture was placed in ice water. The precipitated crude crystals were collected by filtration, washed with water, and dried under reduced pressure.This was purified by silica gel column chromatography to obtain 1.37 g of 1-(p-)luenesulfonyl)-3-acetoxyindole.
20戚のメタノールに溶解した3、0g(9,11a+
mol)の上記化合物を30フラスコに取り導入管上、
反応溶液中にN2を通気する。通気を継続したまま、−
8°Cまで反応溶液を冷却し、滴下ロートより脱酸素化
10%水酸化カリウム水溶液15m1を加え、−8°C
で1時間撹拌反応させてた後、脱酸素化クエン酸溶液(
2N)25dを加え、さらにo ’cで30分間撹拌を
継続する。反応混合物を脱酸素化クロロホルムで抽出し
、クロロホルム層を無水硫酸マグネシウムで乾燥後減圧
乾固し、粗1−(p−)ルエンスルホニル)−インドキ
シル2.34gを得る。3.0 g (9,11a+) dissolved in methanol of 20 relatives
mol) of the above compound was placed in a 30 flask and placed on the introduction tube.
Bubble N2 into the reaction solution. While continuing ventilation, -
Cool the reaction solution to 8°C, add 15ml of deoxygenated 10% potassium hydroxide aqueous solution from the dropping funnel, and cool to -8°C.
After reacting with stirring for 1 hour, deoxygenated citric acid solution (
Add 25d of 2N) and continue stirring at o'c for another 30 minutes. The reaction mixture is extracted with deoxygenated chloroform, and the chloroform layer is dried over anhydrous magnesium sulfate and evaporated to dryness to obtain 2.34 g of crude 1-(p-)luenesulfonyl)-indoxyl.
2、Og(6,96mmol)の粗1−(p−トルエン
スルホニル)−インドキシルと、3.38 g (13
,9mmol)のN−(p−トルエンスルホニル)−L
−アラニンを脱酸素化塩化メチレン12mに溶解し冷却
下、610mg(5,0mn+ol)のジメチルアミノ
ピリジンと2.87 g(13,9mmol)のジシク
ロへキシルカルボジイミドを加えN2気流中室温で10
時間撹拌反応した。反応混合物を減圧濃縮後、シリカゲ
ルカラムクロマトグラフィーで精製し3.11 g (
6,07mmol)の1−(p−トルエンスルホニル)
−3−(N −(p−)ルエンスルホニル)−L−ア
ラニルオキシ)−インドールを得た。2, Og (6,96 mmol) of crude 1-(p-toluenesulfonyl)-indoxyl and 3.38 g (13
, 9 mmol) of N-(p-toluenesulfonyl)-L
-Alanine was dissolved in 12 m of deoxygenated methylene chloride, and under cooling, 610 mg (5.0 mn+ol) of dimethylaminopyridine and 2.87 g (13.9 mmol) of dicyclohexylcarbodiimide were added, and the mixture was heated for 10 min at room temperature in a stream of N2.
The reaction was stirred for hours. After concentrating the reaction mixture under reduced pressure, it was purified by silica gel column chromatography to give 3.11 g (
6,07 mmol) of 1-(p-toluenesulfonyl)
-3-(N-(p-)luenesulfonyl)-L-alanyloxy)-indole was obtained.
NMR(δppm、 CDCj! z)6.86−8.
08(m、13H)、5.50(m、18)、4.70
(m。NMR (δppm, CDCj!z) 6.86-8.
08 (m, 13H), 5.50 (m, 18), 4.70
(m.
IH)、2.48(s、3H)、2.46(s、3■)
、1.64(d、3H)IR(シew−’−,CHCj
!3) 1750実施例4
1−メチルスルホニル−3−(N−(p−トルエンスル
ホニル)−L−アラニルオキシ〕−インドール
So、−CH。IH), 2.48 (s, 3H), 2.46 (s, 3■)
, 1.64(d,3H)IR(sew-'-,CHCj
! 3) 1750 Example 4 1-Methylsulfonyl-3-(N-(p-toluenesulfonyl)-L-alanyloxy]-indole So, -CH.
(T、は実施例1に同じ)
20dの無水酢酸に3.0g(10,9mn+ol)の
N−メチルスルホニルフェニルグリシン−2−カルボン
酸と、1.7gの酢酸ナトリウムを加え5時間加熱還流
した。(T is the same as in Example 1) 3.0 g (10.9 mn+ol) of N-methylsulfonylphenylglycine-2-carboxylic acid and 1.7 g of sodium acetate were added to 20 d of acetic anhydride and heated under reflux for 5 hours. .
反応混合物を氷水中に投入し、析出する粗結晶をろ集し
水洗減圧乾燥した。粗生成物をシリカゲルカラムクロマ
トグラフィーで精製し1.26gの1−メチルスルホニ
ル−3−アセトキシインドールを得る。The reaction mixture was poured into ice water, and the precipitated crude crystals were collected by filtration, washed with water, and dried under reduced pressure. The crude product was purified by silica gel column chromatography to obtain 1.26 g of 1-methylsulfonyl-3-acetoxiindole.
20dのメタノールに溶解した3、0g(11,8m+
*ol)の上記化合物をし30フラスコに取り導入管上
、反応溶液中にN2を通気する。通気を継続したまま、
−8°Cまで反応溶液を冷却し、滴下ロートより脱酸素
化10%水酸化カリウム水溶液16dを加え、−8°C
で1時間撹拌反応させた後、脱酸素化クエン酸水溶液(
2N)25dを加え、さらに0°Cで30分間撹拌を継
続する。反応混合物を脱酸素化クロロホルムで抽出し、
クロロホルム層を無水硫酸マグネシウムで乾燥後減圧乾
固し、2.17gの1−メチルスルホニルインドキシル
を得た。3.0 g (11.8 m+) dissolved in 20 d of methanol
*ol) The above compound was placed in a 30 flask, and N2 was bubbled into the reaction solution over the inlet tube. While continuing ventilation,
Cool the reaction solution to -8°C, add 16d of deoxygenated 10% potassium hydroxide aqueous solution from the dropping funnel, and cool to -8°C.
After reacting with stirring for 1 hour, deoxygenated citric acid aqueous solution (
Add 25 d of 2N) and continue stirring at 0°C for an additional 30 minutes. The reaction mixture was extracted with deoxygenated chloroform,
The chloroform layer was dried over anhydrous magnesium sulfate and then dried under reduced pressure to obtain 2.17 g of 1-methylsulfonylindoxyl.
2.0g(9,47mmol)の粗1−メチルスルホニ
ルインドキシルと、4.60g(18,9mmol)の
N−P−トルIンスルホニルーL−アラニンを脱酸素化
塩化メチレン15Ildlに溶解し冷却下、733 m
g(6,0mmol)のジメチルアミノピリジンと3.
90g(18,9mmoりのジシクロへキシルカルボジ
イミドを加え、N2気流中室温で10時間撹拌反応した
。反応混合物を減圧濃縮後シリカゲルカラムクロマトグ
ラフィーで精製し、3.05g(6,99ma+ol)
の1−メチルスルホニル−3−(N−(p−)ルエンス
ルホニル)−L−アラニルオキシ〕−インドールを得る
。2.0 g (9.47 mmol) of crude 1-methylsulfonylindoxyl and 4.60 g (18.9 mmol) of N-P-tolu Isulfonyl-L-alanine were dissolved in 15 Ildl of deoxygenated methylene chloride and cooled. 733 m
g (6.0 mmol) of dimethylaminopyridine and 3.
90 g (18.9 mmol) of dicyclohexylcarbodiimide was added, and the reaction was stirred at room temperature in a N2 stream for 10 hours. The reaction mixture was concentrated under reduced pressure and purified by silica gel column chromatography to give 3.05 g (6.99 mmol).
1-methylsulfonyl-3-(N-(p-)luenesulfonyl)-L-alanyloxy]-indole is obtained.
NMR(δppm、 CDC13)
6.80−7.98(n+、9B)、5.62(m、I
H)+4.18(m、IH)。NMR (δppm, CDC13) 6.80-7.98 (n+, 9B), 5.62 (m, I
H) +4.18 (m, IH).
2.84(s、31り 、2.44(s、3H) 、
1.64(d、3H)IR(シcm−’、CHCj!s
) 1750実施例5
〔組成物の製造例1〕
溶液■
0、LM Tris−HCj2緩衝液
100dおよび
溶液■
エタノール/デカノール 98:2 100dを
混合し、本発明に係るエステラーゼ又はプロテアーゼ測
定用試験組成物を得た。2.84 (s, 31ri), 2.44 (s, 3H),
1.64(d,3H)IR(shicm-',CHCj!s
) 1750 Example 5 [Composition Production Example 1] Solution ■ 0, LM Tris-HCj2 buffer
100d and solution (1) ethanol/decanol 98:2 100d were mixed to obtain a test composition for measuring esterase or protease according to the present invention.
実施例6
〔組成物の製造例2〕
溶液I
O,IM Tris−H(F!緩衝液
100dおよび
溶液■
アセトン/デカノール 98:2 100m
j!を混合し、本発明に係るエステラーゼ又はプロテア
ーゼ測定用試験組成物を得た。Example 6 [Production Example 2 of Composition] Solution IO, IM Tris-H (F! Buffer
100d and solution■ Acetone/decanol 98:2 100m
j! were mixed to obtain a test composition for measuring esterase or protease according to the present invention.
実施例7
〔試験紙の製造例1]
溶液■
0、IM Tris−HCj!緩衝液
100d溶液■
をエタノール/1−デカノール98:2100dに溶解
する。Example 7 [Test paper production example 1] Solution ■ 0, IM Tris-HCj! buffer solution
100d solution (1) is dissolved in ethanol/1-decanol 98:2100d.
濾紙を溶液■に含浸し60°Cで50分間乾燥し、次い
で溶液■に含浸し40°Cで20分間乾燥することによ
り、本発明に係る試験紙を得た。A test paper according to the present invention was obtained by impregnating a filter paper with solution (1) and drying it at 60°C for 50 minutes, then impregnating it with solution (2) and drying it at 40°C for 20 minutes.
実施例8
〔試験紙の製造例2)
溶液■
0、IM Tris−H(J!1,1街液
10〇−溶液■
をアセトン/デカノール 98:2 LooIRftに
溶解する。Example 8 [Test paper production example 2] Solution ■ 0, IM Tris-H (J!1,1 street liquid
100 - Dissolve solution ■ in acetone/decanol 98:2 LooIRft.
濾紙を溶液Iに含浸し、60°Cで50分間乾燥し、次
いで溶液■に含浸し40°Cで20分間乾燥することに
より、本発明に係る試験紙を得た。A test paper according to the present invention was obtained by impregnating a filter paper with Solution I and drying it at 60°C for 50 minutes, then impregnating it with Solution II and drying it at 40°C for 20 minutes.
上記実施例7.8で得られた試験紙を尿中に1秒間含浸
させる。前記試験紙の呈色を時間の経過につれて目視に
より読みとる。The test strip obtained in Example 7.8 above is soaked in urine for 1 second. The color development of the test paper is visually read over time.
その結果、実施例7.8ともに白血球10/ill尿の
検出を90秒の判定時間で行うことができ、試験紙の呈
色は白色から紫色となった。As a result, in both Examples 7 and 8, it was possible to detect 10 leukocytes/ill urine in a determination time of 90 seconds, and the color of the test paper changed from white to purple.
本発明によれば、新規なN−置換インドールエステル化
合物が提供される。According to the present invention, novel N-substituted indole ester compounds are provided.
さらに本発明によれば、かかるN−置換インドールエス
テル化合物の有利な製造法が提供される。Furthermore, the present invention provides an advantageous method for producing such N-substituted indole ester compounds.
また、本発明のN−置換インドールエステル化合物はエ
ステラーゼ又はプロテアーゼ、特に白血球の検出に有効
に利用される。Furthermore, the N-substituted indole ester compounds of the present invention are effectively used for detecting esterases or proteases, particularly leukocytes.
従来知られている3−(N−(p−)ルエンスルホニル
)−L−アラニルオキシ)インドールと2−メトキシ−
4−モルホリノペンゾールジアゾニウム−テトラクロル
ジンケートの組合せによる成分の試験紙での判定に要す
る時間が120秒であるが、今回開発した試験紙は90
秒で判定できることから、本発明はより性能的に優れた
試験組成物ならびに試験具を提供するものである。Conventionally known 3-(N-(p-)luenesulfonyl)-L-alanyloxy)indole and 2-methoxy-
It takes 120 seconds to determine the ingredients of the combination of 4-morpholinopenzolediazonium-tetrachlorzincate using a test paper, but the test paper we developed this time takes 90 seconds.
Since the determination can be made in seconds, the present invention provides a test composition and a test device with superior performance.
このように本発明のN−置換インドールエステル化合物
(Ilはエステラーゼ又はプロテアーゼ測定用の基質と
して優れた性能を有している。As described above, the N-substituted indole ester compound (Il) of the present invention has excellent performance as a substrate for measuring esterase or protease.
Claims (1)
アリールオキシ基を示すが、ハロゲン原子、アルコキシ
基またはニトロ基で置換されていてもよい、または、式
中R^1はアルキルスルホニル基またはアリールスルホ
ニル基を示す。 R^2は水素原子、ハロゲン原子、ヒドロキシ基、カル
ボキシル基、アシルアミノ基、ニトロ基、カルボキシル
基、アルコキシカルボニル基、アルコキシ基またはアミ
ド基を表す。X、Yはアミノ基の常用保護基を表す。〕 で表されるN−置換インドールエステル化合物。 2)上記式( I )中、R^1がメトキシ基、ベンジル
オキシ基、p−トルエンスルホニル基、またはメチルス
ルホニル基である特許請求の範囲第1項に記載の化合物
。 3)上記式( I )中のN−置換インドールエステル化
合物が、1−メトキシ−3−〔N−(p−トルエンスル
ホニル)−L−アラニルオキシ〕インドール、1−ベン
ジルオキシ−3−〔N−(p−トルエンスルホニル)−
L−アラニルオキシ〕−5−ブロモインドール,1−(
p−トルエンスルホニル)−3−〔N−(p−トルエン
スルホニル)−L−アラニルオキシ〕インドールまたは
1−メチルスルホニル−3−〔N−(p−トルエンスル
ホニル)−L−アラニルオキシ〕インドールである特許
請求の範囲第1項に記載の化合物。 4)一般式(II) ▲数式、化学式、表等があります▼(II) 〔式中R^1はアルコキシ基、アルアルコキシ基または
アリールオキシ基を示すが、ハロゲン原子、アルコキシ
基またはニトロ基で置換されていてもよい。または、式
中R^1はアルキルスルホニル基またはアリールスルホ
ニル基を示す。 R^2は水素原子、ハロゲン原子、ヒドロキシ基カルボ
キシル基、アシルアミノ基、ニトロ基、カルボキシル基
、アルコキシカルボニル基、アルコキシ基またはアミド
基を表す。〕 で表される化合物と、 一般式(III) ▲数式、化学式、表等があります▼(III) 〔式中Zはヒドロキシ基、ハロゲン原子、アルコキシカ
ルボニルオキシ基またはイミダゾール基等を示す。X、
Yはアミノ基の常用保護基を表す。〕 で表される化合物とを縮合させることを特徴とする一般
式( I ) ▲数式、化学式、表等があります▼( I ) 〔式中R^1、R^2、XとYは前述したものと同一意
義を有する。〕 で表されるN−置換インドールエステル化合物の製造法
。 5)請求項1乃至3のいずれかに記載のN−置換インド
ールエスル化合物および一般式 ▲数式、化学式、表等があります▼(IV)または▲数式
、化学式、表等があります▼(V) 〔式中R^3はアルキル基、アルコキシ基、ハロゲン原
子又は水素原子を示し、R^4はアルキレン基を示し、
m、nは同一又は異なった1、2、3の整数を示し、Z
は安定化性アニオンを示す。又Aは ▲数式、化学式、表等があります▼ アルキルアミン又は酸素原子を示す。〕 で表されるジアゾニウム塩化合物を含有するエステラー
ゼまたはプロテアーゼ測定様試験組成物。 6)上記式(IV)または(V)において、R^3がメト
キシ基である特許請求の範囲第5項記載の組成物。 7)請求項5または6記載の組成物を担体に担持させて
なるエステラーゼ又はプロテアーゼ測定用試験具。[Claims] 1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (I) [In the formula, R^1 represents an alkoxy group, an aralkoxy group, or an aryloxy group, but a halogen atom, an alkoxy group, or It may be substituted with a nitro group, or R^1 in the formula represents an alkylsulfonyl group or an arylsulfonyl group. R^2 represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxyl group, an acylamino group, a nitro group, a carboxyl group, an alkoxycarbonyl group, an alkoxy group, or an amide group. X and Y represent commonly used protecting groups for amino groups. ] N-substituted indole ester compound represented by these. 2) The compound according to claim 1, wherein R^1 in the above formula (I) is a methoxy group, a benzyloxy group, a p-toluenesulfonyl group, or a methylsulfonyl group. 3) The N-substituted indole ester compound in the above formula (I) is 1-methoxy-3-[N-(p-toluenesulfonyl)-L-alanyloxy]indole, 1-benzyloxy-3-[N-( p-toluenesulfonyl)-
L-alanyloxy]-5-bromoindole, 1-(
A patent claim that is p-toluenesulfonyl)-3-[N-(p-toluenesulfonyl)-L-alanyloxy]indole or 1-methylsulfonyl-3-[N-(p-toluenesulfonyl)-L-alanyloxy]indole A compound according to item 1 of the scope. 4) General formula (II) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (II) [In the formula, R^1 represents an alkoxy group, aralkoxy group, or aryloxy group, but it is not a halogen atom, an alkoxy group, or a nitro group. May be replaced. Alternatively, R^1 in the formula represents an alkylsulfonyl group or an arylsulfonyl group. R^2 represents a hydrogen atom, a halogen atom, a hydroxy carboxyl group, an acylamino group, a nitro group, a carboxyl group, an alkoxycarbonyl group, an alkoxy group, or an amide group. ] Compounds represented by the general formula (III) ▲Mathematical formulas, chemical formulas, tables, etc.▼(III) [In the formula, Z represents a hydroxy group, a halogen atom, an alkoxycarbonyloxy group, or an imidazole group. X,
Y represents a commonly used protecting group for amino groups. ] General formula (I) characterized by condensation with the compound represented by ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) It has the same meaning as a thing. ] A method for producing an N-substituted indole ester compound represented by: 5) The N-substituted indole ester compound according to any one of claims 1 to 3 and the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (IV) or ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (V) [In the formula, R^3 represents an alkyl group, an alkoxy group, a halogen atom, or a hydrogen atom, and R^4 represents an alkylene group,
m and n are the same or different integers of 1, 2, and 3, and Z
indicates a stabilizing anion. Also, A ▲ has mathematical formulas, chemical formulas, tables, etc. ▼ indicates an alkylamine or an oxygen atom. ] An esterase or protease measurement-like test composition containing a diazonium salt compound represented by: 6) The composition according to claim 5, wherein in the above formula (IV) or (V), R^3 is a methoxy group. 7) A test device for measuring esterase or protease, comprising a carrier supporting the composition according to claim 5 or 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63215379A JPH01139564A (en) | 1987-08-31 | 1988-08-30 | N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62-216781 | 1987-08-31 | ||
JP21678187 | 1987-08-31 | ||
JP63215379A JPH01139564A (en) | 1987-08-31 | 1988-08-30 | N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01139564A true JPH01139564A (en) | 1989-06-01 |
Family
ID=26520847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63215379A Pending JPH01139564A (en) | 1987-08-31 | 1988-08-30 | N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01139564A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0661280A1 (en) * | 1993-12-29 | 1995-07-05 | Kyoto Daiichi Kagaku Co., Ltd. | Novel amino acid ester and reagent composition for detecting leucocytes or elastase in body liquid |
KR100451414B1 (en) * | 2001-12-31 | 2004-10-06 | 한국과학기술연구원 | Indol derivatives and a preparation method thereof |
WO2004048328A3 (en) * | 2002-11-28 | 2004-10-28 | Suven Life Sciences Ltd | N-arylsulfonyl-3-aminoalkoxyindoles |
US20210031182A1 (en) * | 2018-01-31 | 2021-02-04 | Kikoh Corporation | Kit having peripheral-circle compatible scaling structure for testing somatic cells in raw milk |
-
1988
- 1988-08-30 JP JP63215379A patent/JPH01139564A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0661280A1 (en) * | 1993-12-29 | 1995-07-05 | Kyoto Daiichi Kagaku Co., Ltd. | Novel amino acid ester and reagent composition for detecting leucocytes or elastase in body liquid |
KR100451414B1 (en) * | 2001-12-31 | 2004-10-06 | 한국과학기술연구원 | Indol derivatives and a preparation method thereof |
WO2004048328A3 (en) * | 2002-11-28 | 2004-10-28 | Suven Life Sciences Ltd | N-arylsulfonyl-3-aminoalkoxyindoles |
JP2006511506A (en) * | 2002-11-28 | 2006-04-06 | スベン ライフ サイエンシズ リミティド | N-arylsulfonyl-3-aminoalkoxyindole |
EA009193B1 (en) * | 2002-11-28 | 2007-12-28 | Сувен Лайф Сайенсиз Лимитед | N-arylsulfonyl-3-aminoalkoxyindoles |
US7718690B2 (en) | 2002-11-28 | 2010-05-18 | Venkata Satya Nirogi Ramakrishna | N-arylsulfonyl-3-aminoalkoxyindoles |
JP4782425B2 (en) * | 2002-11-28 | 2011-09-28 | スベン ライフ サイエンシズ リミティド | N-arylsulfonyl-3-aminoalkoxyindole |
EP1567492B1 (en) * | 2002-11-28 | 2013-05-22 | Suven Life Sciences Limited | N-arylsulfonyl-3-aminoalkoxyindoles |
US20210031182A1 (en) * | 2018-01-31 | 2021-02-04 | Kikoh Corporation | Kit having peripheral-circle compatible scaling structure for testing somatic cells in raw milk |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH01139564A (en) | N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound | |
JPH083144A (en) | Quinazoline and quinoline derivative | |
JPH0873422A (en) | New amino acid ester and method for detecting leukocyte, esterase or protease | |
JPH02174769A (en) | Production method of 1,4-diazabicyclo[3.2.2]nonane | |
JPS59110690A (en) | Benzopyran derivative | |
JPH06508851A (en) | Method for producing 13α-cinnamoyl baccatin III or -10-deacetylbaccatin III | |
JPS60139646A (en) | naphthalene derivatives | |
JPS6328418B2 (en) | ||
JP3210412B2 (en) | New isoquinoline carboxylic acid derivatives | |
JP2501339B2 (en) | Naphthalene derivative | |
JP3760484B2 (en) | Thieno [2,3-d] pyrimidin-4-one derivatives | |
JPH03210193A (en) | Measuring instrument for hydrolase | |
JP3183724B2 (en) | Amidinocyclohexane derivative | |
JPS60193966A (en) | N-nicotinoylpiperazine derivative and its preparation | |
JPS6383073A (en) | Benzo[α]phenazine derivatives | |
US5789618A (en) | Synthetic method for a halogen-containing condensation product | |
JPH0859658A (en) | New isoquinoline derivative and its acid addition salt | |
JPS6064976A (en) | N-substituted flavone-8-carboxamide derivative, and its preparation | |
JPH01186861A (en) | Peroxy ester compound, production thereof and test composition and test tool using said compound | |
KR810000293B1 (en) | Method for preparing substituted amino quinazoline derivatives | |
JPS58225079A (en) | Benzoylpiperazines | |
JPH0418075A (en) | 5-dialkylamino-2-chloro-8-formylquinolines and production thereof | |
JPS611677A (en) | Piperazine derivative and its production | |
JPS60248663A (en) | Aminophenylthioacetic acid compound and its preparation | |
JPS61205239A (en) | N-cyclopropylaniline derivative and production thereof |